Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity.
Gragnani L, Visentini M, Lorini S, Santini SA, Lauletta G, Mazzaro C, Urraro T, Quartuccio L, Cacciapaglia F, Ruscitti P, Tavoni A, Marri S, Cusano G, Petraccia L, Naclerio C, Treppo E, Del Frate G, Di Cola I, Raimondo V, Scorpiniti D, Monti M, Puccetti L, Elia G, Fallahi P, Basili S, Scarpato S, Iannone F, Casato M, Antonelli A, Zignego AL, Ferri C. Gragnani L, et al. Among authors: visentini m. J Clin Immunol. 2023 May;43(4):680-691. doi: 10.1007/s10875-023-01444-4. Epub 2023 Feb 16. J Clin Immunol. 2023. PMID: 36795264 Free PMC article.
A lymphotactin-producing monoclonal T-cell lymphoproliferative disorder with extreme lymphocytopenia and progressive leukoencephalopathy.
Visentini M, Carbonari M, Ghia E, De Propriis S, Guarini A, Girmenia C, Giannini G, Sabattini E, Ceccarini C, Zamarchi R, Giangaspero F, Novelli A, Amadori A, Pileri SA, Fiorilli M. Visentini M, et al. Leuk Lymphoma. 2006 Jul;47(7):1421-3. doi: 10.1080/10428190600581807. Leuk Lymphoma. 2006. PMID: 16923584 No abstract available.
Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells.
Rakhmanov M, Keller B, Gutenberger S, Foerster C, Hoenig M, Driessen G, van der Burg M, van Dongen JJ, Wiech E, Visentini M, Quinti I, Prasse A, Voelxen N, Salzer U, Goldacker S, Fisch P, Eibel H, Schwarz K, Peter HH, Warnatz K. Rakhmanov M, et al. Among authors: visentini m. Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13451-6. doi: 10.1073/pnas.0901984106. Epub 2009 Jul 29. Proc Natl Acad Sci U S A. 2009. PMID: 19666505 Free PMC article.
Correction to: Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease.
Ferri F, Mischitelli M, Tozzi G, Messina E, Mignini I, Mazzuca S, Pellone M, Parisse S, Marrapodi R, Visentini M, Baratta F, Del Ben M, Pastori D, Perciballi R, Attilia ML, Carbone M, De Santis A, Violi F, Angelico F, Corradini SG. Ferri F, et al. Among authors: visentini m. Clin Transl Gastroenterol. 2020 Apr;11(4):e00171. doi: 10.14309/ctg.0000000000000171. Clin Transl Gastroenterol. 2020. PMID: 32251015 Free PMC article. No abstract available.
Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells.
Camponeschi A, Kläsener K, Sundell T, Lundqvist C, Manna PT, Ayoubzadeh N, Sundqvist M, Thorarinsdottir K, Gatto M, Visentini M, Önnheim K, Aranburu A, Forsman H, Ekwall O, Fogelstrand L, Gjertsson I, Reth M, Mårtensson IL. Camponeschi A, et al. Among authors: visentini m. J Exp Med. 2022 Sep 5;219(9):e20220201. doi: 10.1084/jem.20220201. Epub 2022 Jul 12. J Exp Med. 2022. PMID: 35819358 Free PMC article.
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
Frigeni M, Besson C, Visco C, Fontaine H, Goldaniga M, Visentini M, Pulsoni A, Torres HA, Peveling-Oberhag J, Rossotti R, Zaja F, Rigacci L, Merli M, Dorival C, Alric C, Piazza F, Gentile M, Ferrari A, Pirisi M, Nassi L, Rattotti S, Frustaci A, Milella M, Cencini E, Defrancesco I, Ferretti VV, Bruno R, Hermine O, Arcaini L. Frigeni M, et al. Among authors: visentini m. Leukemia. 2020 May;34(5):1462-1466. doi: 10.1038/s41375-019-0687-2. Epub 2019 Dec 13. Leukemia. 2020. PMID: 31836855 No abstract available.
Efficacy of low-dose rituximab for mixed cryoglobulinemia.
Visentini M, Granata M, Veneziano ML, Borghese F, Carlesimo M, Pimpinelli F, Fiorilli M, Casato M. Visentini M, et al. Clin Immunol. 2007 Oct;125(1):30-3. doi: 10.1016/j.clim.2007.06.008. Epub 2007 Aug 9. Clin Immunol. 2007. PMID: 17692572 Clinical Trial.
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.
Visentini M, Ludovisi S, Petrarca A, Pulvirenti F, Zaramella M, Monti M, Conti V, Ranieri J, Colantuono S, Fognani E, Piluso A, Tinelli C, Zignego AL, Mondelli MU, Fiorilli M, Casato M. Visentini M, et al. Autoimmun Rev. 2011 Sep;10(11):714-9. doi: 10.1016/j.autrev.2011.04.033. Epub 2011 May 5. Autoimmun Rev. 2011. PMID: 21570494 Clinical Trial.
104 results